According to a new report ‘Indian Surgical Landscape and Surgical Consumables Market’ by 1Lattice indicates that India’s healthcare sector is undergoing a significant transformation, as its surgical environment is rapidly changing due to a growing...
During intraday trading on Monday, GlaxoSmithKline Pharmaceuticals saw its share price shoot up by 5% to Rs 2,640 on the BSE, with a three-month high. The BSE Sensex dropped by...
Zydus Lifesciences, a global health care company focused solely on affordable medicines, has received final USFDA approval for Ibuprofen and Famotidine tablet
The chairman of Zydus Lifesciences, Pankaj R Patel, stated on Friday that the Indian pharmaceutical industry can produce 100 new drugs for global markets by 2047, supported by improved research and development initiatives...
Pharmaceutical industry Cipla has obtained final approval from the United States Food and Drug Administration (USFDA) for the New Drug Application (‘NDA’) it submitted for ‘Nilotinib Capsules 50, 150, and 200 mg’...
On February 19, pharmaceutical stocks faced pressure after remarks from US President Donald Trump, indicating that the US could implement tariffs close to 25% on imports of pharmaceuticals, automobiles, and semiconductors...
On Thursday, Sun Pharmaceutical Industries announced that it has requested shareholders' consent for related-party transactions (RPTs) totaling about $1 billion for FY26...
A groundbreaking UK-India initiative, the ‘Living Laboratory’ was officially launched in Pune, India, marking a significant step toward decarbonizing the pharma industry. The state-of-the-art facility that will serve as a
Innocan Pharma Corporation, a leader in the pharmaceutical and biotechnology sectors, is pleased to declare that it has received a patent in India for a prolonged-release pharmaceutical formulation that uses liposomes to encapsulate cannabinoids...
The maximum retail price (MRP) of medications and formulations that are no longer subject to customs duty has been adjusted by the National Pharmaceutical Pricing Authority (NPPA) in accordance with this year's budget.
, CDSCO.jpg)
